{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:30:53Z","timestamp":1792189853397,"version":"4.4.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>Anti-amyloid immunotherapies in Alzheimer's disease (AD) are newly authorized for use in the European Union (AD). In a national online survey in 2024, we aimed to assess French practitioners\u2019 opinion and knowledge regarding indications and risk management plan. Answers were based on clinical trial criteria. On 303 practitioners, most knew general indications except 19.1% who considered prescribing without AD biomarkers. Side effects were correctly identified, but specific knowledge on amyloid-related imaging abnormalities was lacking. Tertiary memory clinic practitioners had better knowledge on indications (p\u2009&lt;\u20090.001) and side effects (p\u2009=\u20090.033).<\/jats:p>","DOI":"10.1177\/13872877261452180","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:41:47Z","timestamp":1780573307000},"page":"611-617","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-amyloid immunotherapies in Alzheimer's disease: Are future prescribers prepared? Insights of a French national survey"],"prefix":"10.1177","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-8736","authenticated-orcid":false,"given":"Karl","family":"G\u00f6tze","sequence":"first","affiliation":[{"name":"IHU Re-Connect, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"Geriatric Daily Hospital Department, Bretonneau Hospital, GHU APHP.Nord, Paris, France"},{"name":"Inserm Unit UMR-S 1144 Therapeutic optimization in neuropsychopharmacology, Paris-Cit\u00e9 University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6858-1982","authenticated-orcid":false,"given":"Felix","family":"Auboeuf-Dominguez","sequence":"additional","affiliation":[{"name":"Medicin Department, P\u00f4le de sant\u00e9 L\u00e9onard de Vinci, Chambray-l\u00e8s-Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Akroum","sequence":"additional","affiliation":[{"name":"Geriatrics Department, Morestel Hospital (Groupement Hospitalier Nord Dauphin\u00e9), Morestel, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire Tourtier","family":"Bellosta","sequence":"additional","affiliation":[{"name":"Neurology Department, Groupe Hospitalier Sud-bretagne, Lorient, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Paquet","sequence":"additional","affiliation":[{"name":"IHU Re-Connect, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"Inserm Unit UMR-S 1144 Therapeutic optimization in neuropsychopharmacology, Paris-Cit\u00e9 University, Paris, France"},{"name":"Cognitive Neurology Center, Lariboisi\u00e8re-Fernand Widal Hospital GHU APHP.Nord, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"Kisunla | European Medicines Agency (EMA). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kisunla (2025 accessed 8 February 2026)."},{"key":"e_1_3_3_3_2","unstructured":"Leqembi | European Medicines Agency (EMA). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/leqembi (2025 accessed 3 December 2025)."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1566067"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70299-6"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad159"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2022.21"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-230099"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207505"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70652"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/imj.16637"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2023.270"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-121648"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70315-0"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100094"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2011.08.012"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7160-3"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/medu.14761"},{"key":"e_1_3_3_21_2","first-page":"65","article-title":"[Biomarkers of Alzheimer\u2019s disease in older and oldest old patients]","volume":"17","author":"Lilamand M","year":"2019","unstructured":"Lilamand M, Cognat E, Goutagny S, et al. [Biomarkers of Alzheimer\u2019s disease in older and oldest old patients]. Geriatr Psychol Neuropsychiatr Vieil 2019; 17: 65\u201372.","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-022-03317-7"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268756"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.3770"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1185-7"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-130485"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/13872877261422452"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207156"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00335-1"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12567"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.4491"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq056"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261452180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877261452180","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261452180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:26:34Z","timestamp":1783412794000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877261452180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1177\/13872877261452180"],"URL":"https:\/\/doi.org\/10.1177\/13872877261452180","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}